Exhibit 99.1 IceCure Medical Reports 2022 Full Year Financial Results & Recent Corporate Developments; Milestone Achievements Expected to Drive Revenue Growth in 2023 ● Rising Utilization of ProSense in the U.S. Market Generates Year-over-Year Consumable Revenue Growth ● Physician Adoption Continues to Grow Ahead of the FDA’s Response to the Company’s Application for Marketing Approval in Breast Cancer Indication ● Regulatory Approval Received in China for Commercial Use of IceSense3 Disposable Cryoprobes, ...